Caption Management’s Q32 Bio QTTB Stock Holding History

Caption Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,339	Closed	-$546K	–	2038
2021 Q4	$546K	Buy	8,339 +2,778	+50%	+$270K	0.01%	1233
2021 Q3	$788K	Buy	+5,561	New	+$708K	0.01%	1088

Other funds holding QTTB

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Caption Management's QTTB Position: Q4 2020 in Review

Caption Management sold out of Q32 Bio (QTTB) in Q4 2020, closing a stake of 200 shares — an estimated $39K sold.

Caption Management first reported a position in QTTB in Q2 2020 and held it in 2 quarters. The position peaked at $763K in Q2 2020. 106 funds tracked by Wall St. Rank hold QTTB as of Q4 2020.

Caption Management reported no remaining Q32 Bio position as of Q4 2020 after selling out during the quarter.
Caption Management sold 200 Q32 Bio shares in Q4 2020, an estimated $39K.
Caption Management first reported a position in Q32 Bio in Q2 2020 and held it in 2 quarters.
Caption Management's Q32 Bio position peaked at $763K in Q2 2020.
106 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2020.

Based on Caption Management's 13F filing for Q4 2020, filed 16 Feb 2021.